From lab to life
mAbxience is a Spanish-based company specializing in the development, production, and commercialization of biopharmaceuticals. With over a decade of expertise, our mission is clear: to provide accessible, affordable medicines across the globe, aiming to enhance the quality of life by ensuring universal access to high-caliber medicines. With two market-approved products and a robust pipeline in development, we have established a B2B presence in over 100 markets. Alongside this, we have formed a network with more than 30 partners and built a dedicated team of over 1,000 professionals. Our three multi-product facilities, located in Europe and South America, have obtained GMP approval from esteemed regulatory bodies, including the FDA, EMA, and others. Furthermore, as a global biopharmaceutical expert, mAbxience specializes in Contract Development and Manufacturing Organization services (CDMO), utilizing advanced technology and innovative platforms to deliver integrated manufacturing solutions. For more insights into mAbxience, our biosimilars and CDMO business, please visit our website (www.mabxience.com)
Biosimilars, Hematology, Autoinmune diseases, Oncology, Biotech, Biotechnology, CDMO, and CMO
mAbxience is a global, vertically integrated fully-fledged biotechnology company, with over a decade of experience in the development, manufacture and commercialization of biopharmaceutical medicines.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Teva Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Teva Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Other 4 Apr 2024 | | |
AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 25 Mar 2021 31 Jan 2024 | | |
Fresenius Medical Care Pharmaceutical, Hospitals and Health Care | Fresenius Medical Care Pharmaceutical, Hospitals and Health Care | Other 31 Mar 2022 4 Apr 2024 | | |
SAP IT services, Software, Software Development | SAP IT services, Software, Software Development | Other 7 Dec 2017 | |